Prognostic value and functional characterization of miR-141 and miR-200c expression levels in resected NSCL

J. Moisés, R. Marrades, R. Tejero, A. Navarro, M. Campayo, N. Viñolas, C. Agustí, A. Saco, M. Paradela, L. Molins, J. Ramirez, M. Monzó (Barcelona, Spain)

Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Session: Pathology and prognostic factors of thoracic tumours
Session type: Poster Discussion
Number: 513
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Abstract

Introduction: Several treatments in non-small cell lung cancer (NSCLC) are histology-dependent, and the need for histology-related markers is increasing. We have examined the prognostic value of the miR-200 family in overall survival (OS) of early-stage NSCLC patients with adenocarcinoma or squamous cell carcinoma (SCC).Experimental design: The expression of all five members of the miR-200 family was determined using TaqMan assays in 155 tumors from resected NSCLC patients. Functional characterization studies were conducted in the H23 lung cancer cell line.Results: High miR-200c expression was associated with shorter OS in the entire cohort (P = 0.024). High miR-200c (P = 0.0004) or miR-141 (P = 0.009) expression correlated with shorter OS in adenocarcinoma – but not in SCC.In the multivariate analysis, the miR-141/200c score emerged as an independent prognostic factor for OS in the entire cohort (OR, 2.787; P = 0.033) and in adenocarcinoma patients (OR, 10.649; P = 0.002) but not in SCC patients. Functional analyses showed that miR-200c, but not miR-141, was related to mesenchymal-epithelial transition (MET) and affected cell migration and E-cadherin levels, while overexpression of miR-141 was associated with higher levels of VEGF in vitro (P = 0.04) and with higher blood microvessel density in patient tumor samples (P < 0.001).Conclusions: High miR-141 and miR-200c expression are associated with poorer outcome in NSCLC patients with adenocarcinoma but not in those with SCC. miR-141 seems to act through angiogenesis, while miR-200c may play a role in the regulation of MET.FIS 12/405, SEPAR, SOCAP, FUCAP.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Moisés, R. Marrades, R. Tejero, A. Navarro, M. Campayo, N. Viñolas, C. Agustí, A. Saco, M. Paradela, L. Molins, J. Ramirez, M. Monzó (Barcelona, Spain). Prognostic value and functional characterization of miR-141 and miR-200c expression levels in resected NSCL. Eur Respir J 2014; 44: Suppl. 58, 513

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The value of miR221 and miR222 as a biomarker in non small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Differences in expression and prognostic values of p16(ink) and VEGF in squamous and adenocarcinoma of the lung
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level?
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Expression analysis of miR-21 in Bulgarian patients with non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016


beta-F1-ATPase expression as a prognostic factor for resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Investigation of survivin gene expression in non small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Micro-RNA screening in neuroendocrine lung tumors: Differential expression of miR-29 family members
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013



Prognostic value of survivin gene promoter polymorphisms in non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Downregulated anti-angiogenic miR-19a, miR-126 and let-7b in non-small lung cancer have poor but different prognostic values in squamous and adenocarcinoma subtypes
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013



Correlation between the simultaneus expression of HER2 and PTEN and the risk of development of metastasis in NSCLC
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Gene expression of EGFR, MINA53,MEN1 and MTOR in NSCLCs
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014


The prognostic impact of PD1 and PDL1 expression in non-small cell lung cancer
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

Proapoptotic effects of PAI-1 protein on lung and prostate cancer cells
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013


Prognostic value of EGFR mutation in NSCLC in surgical stage
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Immunohistochemical expression of nuclear factor kappa-B/p65 and cyclooxygenase-2 in non-small cell lung cancer patients: Prognostic value and impact on survival
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Expression and clinical significance of S100 calcium binding protein A2 in lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016

Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Correlation of miR-422a, miR-21 and miR-155 analysis with hMSH2 and hMLH1 mRNA expression profiles in non-small cell lung carcinomas and their adjacent normal tissues
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013

Polymorphism of HLA-G gene promotor in patients with non small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014